We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$6.02B
AUM Growth
-$105M
Cap. Flow
-$320M
Cap. Flow %
-5.31%
Top 10 Hldgs %
33.88%
Holding
138
New
8
Increased
36
Reduced
78
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 16.95%
2 Consumer Discretionary 14.12%
3 Communication Services 10.81%
4 Industrials 10.37%
5 Consumer Staples 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFY icon
126
Infosys
INFY
$48.4B
$724K 0.01%
81,104
-16,856
-17% -$158K
NBIS
127
Nebius Group N.V.
NBIS
$47.8B
$697K 0.01%
31,900
NKE icon
128
Nike
NKE
$62.7B
$624K 0.01%
11,305
-10,695
-49% -$609K
UE icon
129
Urban Edge Properties
UE
$2.87B
$620K 0.01%
20,762
-719
-3% -$19.3K
BN icon
130
Brookfield
BN
$103B
$595K 0.01%
50,449
-807
-2% -$9.65K
MSFT icon
131
Microsoft
MSFT
$3.35T
$587K 0.01%
11,470
-6,057
-35% -$315K
LKQ icon
132
LKQ Corp
LKQ
$5.76B
$582K 0.01%
18,346
-17,225
-48% -$560K
XYL icon
133
Xylem
XYL
$27.3B
$545K 0.01%
12,201
-9,299
-43% -$404K
NCLH icon
134
Norwegian Cruise Line
NCLH
$8.59B
$482K 0.01%
12,094
KR icon
135
Kroger
KR
$35.4B
$437K 0.01%
+11,869
New +$427K
SPWR
136
DELISTED
SunPower Corporation Common Stock
SPWR
$211K ﹤0.01%
20,782
-19,836
-49% -$234K
MD icon
137
Pediatrix Medical
MD
$2.17B
-17,600
Closed -$1.14M
LVLT
138
DELISTED
Level 3 Communications Inc
LVLT
-16,700
Closed -$883K

Similar funds

Sarasin & Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Sarasin & Partners held 138 positions worth $6.02B, down 1.7% from $6.13B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Sarasin & Partners withdrew a net $320M in Q2 2016, closing 2 positions and reducing 78 holdings. Its most notable exit was Pediatrix Medical, an estimated $1.14M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Sarasin & Partners opened a new position in Mobileye N.V. worth $100M.

  • Sarasin & Partners's largest Q2 2016 buy was Mobileye N.V.: 2,170,999 shares worth $100M.
  • Sarasin & Partners added most to iShares MSCI ACWI ETF in Q2 2016, an estimated $64.1M increase.
  • Sarasin & Partners's biggest Q2 2016 reduction was Walgreens Boots Alliance, cutting an estimated $67.1M.
  • Sarasin & Partners fully exited Pediatrix Medical in Q2 2016, selling an estimated $1.14M.
  • Sarasin & Partners's ten largest holdings make up 34% of its $6.02B portfolio in Q2 2016.
  • Sarasin & Partners opened 8 new positions and closed 2 in Q2 2016.
  • Sarasin & Partners's portfolio value fell 1.7% quarter-over-quarter to $6.02B.

Based on Sarasin & Partners's 13F filing for Q2 2016, filed 14 Jul 2016.